ClinicalTrials.Veeva

Menu

Determination of the Glycemic Index Values of 10 Cereal-based Products

PepsiCo logo

PepsiCo

Status

Completed

Conditions

Low Glycemic Index (GI) Food
Diabetes
Pre Diabetes

Treatments

Other: Glucose solution Day 1, Day 8, and Day 15
Other: Food (cereal). Ten different cereals served once each

Study type

Interventional

Funder types

Industry

Identifiers

NCT06710743
PEP-2402

Details and patient eligibility

About

To determine the Glycemic index values for 10 cereal-based products

Full description

To determine the Glycemic index values for 10 cereal-based products per international standard (ISO26642:2010) for glycemic index determination.

Enrollment

10 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y
  • BMI: 18 - 25.0 kg/m2 (bounds included)
  • Non smokers
  • Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting <6 mM, 2 hr glucose <7.8 mM)
  • Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting
  • Normal sleep patterns (ie. at least 6 hours of sleep per night)
  • The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session.
  • Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion criteria

  • Food allergy or intolerance to the study ingredients (eg. gluten, etc.)
  • Regularly taking prescription medication other than standard contraceptive medication
  • Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis)
  • Suffering from any illness or disease
  • Following a restricted diet
  • Smokers
  • Eating disorders
  • Abnormal glucose tolerance or known history of diabetes mellitus.
  • Individuals currently participating in other acute metabolic studies
  • Failure to meet any one of the inclusion criteria

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 11 patient groups

Reference food
Active Comparator group
Description:
Glucodin powder solution
Treatment:
Other: Glucose solution Day 1, Day 8, and Day 15
Food 1
Experimental group
Description:
Quaker Whole Oats
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 2
Experimental group
Description:
Quaker Quick Cooking White Oats
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 3
Experimental group
Description:
Saffola Oats
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 4
Experimental group
Description:
Quaker Oats
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 5
Experimental group
Description:
Quaker Oats Multigrain
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 6
Experimental group
Description:
Ragi Flakes
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 7
Experimental group
Description:
Bajra Flakes
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 8
Experimental group
Description:
Jowar Flakes
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 9
Experimental group
Description:
Maltabella
Treatment:
Other: Food (cereal). Ten different cereals served once each
Food 10
Experimental group
Description:
FutureLife Smart + White Oats
Treatment:
Other: Food (cereal). Ten different cereals served once each

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems